Bayer didn’t warn of Trasylol’s possible side effects, suit claims

admin | August 31, 2009

Bayer didn’t warn of Trasylol’s possible side effects, suit claims.

A man and woman have filed a suit against Bayer, alleging they were not warned of possible side effects in a drug used to control bleeding in coronary artery bypass grafting.

Don Juan Brown and Jean N. Snyder claim their use of Trasylol led to renal damage, renal insufficiency and multi-system organ failure.

Trasylol, which was approved by the FDA in 1993, is usually supplied as a colorless, sterile isotomic solution that is administered through an IV during coronary artery bypass grafting, according to the complaint filed Aug. 20 in St. Clair County Circuit Court.

In NEJM Editorial, UB Cardiologist Recommends Optimal Medical Therapy, CABG, over PCI in Diabetics with Heart Disease

admin | August 12, 2009

[ photograph ]William E. Boden has written an editorial in the New England Journal of Medicine that urges caution about new research on diabetics with coronary disease.

Release Date: June 7, 2009

BUFFALO, N.Y. — In an editorial in the current issue of the New England Journal of Medicine (NEJM), William E. Boden, M.D., professor of medicine and preventive medicine at the University at Buffalo, recommends that the results of the BARI-2D Trial published in that edition must be interpreted with “considerable caution.”

The editorial is titled “Diabetes with Coronary Disease — A Moving Target Amid Evolving Therapies?”

Dr. Dean Ornish: Resuscitating Health Care Reform

admin | August 10, 2009

Mon, 08/10/2009 - 05:01 — popdd.com - Health reform is in danger of failing because the focus has been too much on who is covered and not enough on what is covered. Health care reform is primarily about health insurance reform, with the main battle being over coverage and the payment system.

Of course, we need to provide coverage for the 48 million Americans who do not have health insurance. It is morally indefensible that we have not already done so.

Buyer Beware: Statins To Lower Cholesterol Are Not a Panacea

admin | July 29, 2009

I’m sure that many of you read about the study showing that Crestor, a popular statin drug manufactured by AstraZeneca, has been found to confer an additional and potentially even greater benefit than its ability to lower cholesterol. Researchers, funded by AstraZeneca, wanted to explain why half of the people who have heart attacks and strokes also have low cholesterol. They set out to determine whether inflammation, as measured by a C-reactive protein test (CRP), was an independent risk factor for cardiovascular disease. Not surprisingly, they found that it was. They also found that Crestor lowered inflammation. Now, the study’s researchers and others are recommending that anyone with inflammation (elevated CRP) take a statin to prevent heart disease–even those who are healthy and not at risk for heart disease. My advice? Buyer beware!

Bypass or Angioplasty No Better Than Drug Therapy in Reducing Deaths Among Patients With Type 2 Diabetes and Heart Disease

admin | July 22, 2009

International Multicenter Study Led by the University of Pittsburgh Published in New England Journal of Medicine and Presented at American Diabetes Association 69th Scientific Sessions

NEW ORLEANS, June 7, 2009 – There is no difference in mortality among patients with type 2 diabetes and stable heart disease who received prompt bypass surgery or angioplasty compared to drug therapy alone, according to a landmark study focused exclusively on patients with both conditions. The study, which was led by investigators at the University of Pittsburgh Graduate School of Public Health, published in the June 11 issue of the New England Journal of Medicine and presented at the American Diabetes Association 69th Scientific Sessions, also found that while prompt bypass in patients with more severe heart disease did not lower mortality, it lowered their risk of subsequent major cardiac events.

Stents no better than heart drugs in diabetics

admin | July 14, 2009

By Julie Steenhuysen

Monday, 8 June 2009

CHICAGO (Reuters) - Diabetics with stable heart disease do just as well taking drugs alone as getting quick angioplasty or bypass surgery to open blocked heart arteries, U.S. researchers said on Sunday.

They said patients advised to have angioplasty and a heart stent to restore blood flow and ease chest pain could safely wait and give drugs a chance to work.

But those with more severe disease sent for more invasive heart bypass surgery might be able to avoid a future heart attack if they have the surgery right away.

What Is Angina Heart Disease?

admin | July 14, 2009

By Yogesh Mishra
06 Jul 2009

Angina heart disease is a fatal condition occurring due to myocardial ischemia as a result of the loss of balance between myocardial blood supply and demand for oxygen.

The contraction of coronary arteries mostly causes disruption in blood supply resulting in arteriosclerosis and pain. This pain mostly occurs due to exertion particularly during walk. Climbing of stairs also leads to anginal pain.

Those with angina heart disease must exercise caution besides taking measures for recovery considering the deadly nature of this condition.

Soothing Angina

admin | July 14, 2009

By Matthew Herper and Robert Langreth
07.13.09

One million Americans suffer heart attacks every year. Quickly getting their arteries propped open with stents saves lives, studies have found. But millions more develop heart symptoms gradually. Usually it comes in the form of angina, a squeezing pain in the chest or arms caused by clogged arteries that starve the heart muscle of oxygen. The pain comes with exercise or stress, and then goes away.

FDA approves Effient to reduce risk of heart attack in angioplasty patients

admin | July 14, 2009

WASHINGTON, July 10 (Xinhua) — The U.S. Food and Drug Administration (FDA) has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.

    During an angioplasty, a balloon is used to open the artery that has been narrowed by atherosclerotic plaque. Often, a tiny wire mesh scaffold (stent) is inserted into the blood vessel to help keep the artery open after the procedure.

    Platelets in the blood can clump around the procedure site, causing clots that can lead to heart attack, stroke, and death.

Various Heart Problems and Their Treatment

admin | July 14, 2009

Introduction

Heart disease is a general term that refers to a variety of acute and chronic medical conditions that affect one or more of the components of the heart. . Diseases affecting the heart may be structural or functional. Anything that damages the heart or decreases the heart’s supply of oxygen, makes it less efficient, reduces its ability to fill and pump, will disrupt the coordinated relationship between the heart, kidneys, and blood vessels and will harm not only the heart but the rest of the body as well.

Cardiac Care Options

Treatment
Cost
Invasive?
CABG
$$$$$
Yes
TMR
$$$$
Yes
Angio/Stent
$$$$
Yes
Medicine
$$
No
ECP
$
No
Rehab
$
No

For more information about each cardiac treatment please click on each treatment title or one of the tabs at the top of the page.

 


VascuFlo, Inc.

The EECP Heart Centers
"Unlocking Your Heart's Natural Bypass"
(716) 681-2968
________


VascuScript
"Reliable - Professional - Honest"
(716) 681-2968
________


External Counterpulsation Research Foundation
Dedicated to the advancement and expanding the use of External Counterpulsation therapy.
(716) 681-2968
________


Vascuvision
________